CAPPELLINI, Alessandra
 Distribuzione geografica
Continente #
EU - Europa 1.678
NA - Nord America 1.395
AS - Asia 446
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 5
SA - Sud America 2
AF - Africa 1
Totale 3.540
Nazione #
US - Stati Uniti d'America 1.391
IE - Irlanda 530
SE - Svezia 355
CN - Cina 242
DE - Germania 237
UA - Ucraina 237
IT - Italia 160
TR - Turchia 153
FI - Finlandia 60
GB - Regno Unito 47
BE - Belgio 19
VN - Vietnam 16
IN - India 15
EU - Europa 13
FR - Francia 12
SG - Singapore 7
HK - Hong Kong 6
AU - Australia 4
RU - Federazione Russa 4
CA - Canada 3
JP - Giappone 3
NL - Olanda 3
PL - Polonia 3
RO - Romania 3
CZ - Repubblica Ceca 2
DK - Danimarca 2
LU - Lussemburgo 2
AT - Austria 1
BR - Brasile 1
CL - Cile 1
GR - Grecia 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
NZ - Nuova Zelanda 1
PA - Panama 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 3.540
Città #
Dublin 530
Chandler 366
Jacksonville 181
Izmir 150
Rome 93
Ann Arbor 79
Wilmington 77
Nanjing 73
Woodbridge 62
Lawrence 46
Princeton 46
Boardman 42
Brooklyn 37
Ashburn 29
Beijing 29
Ogden 29
Nanchang 28
Brandenburg 25
Bologna 23
Brussels 19
Dearborn 19
Helsinki 18
New York 18
Changsha 16
Dong Ket 16
Des Moines 14
Inglewood 14
Jiaxing 13
Orange 13
Hebei 12
Kunming 12
Milan 12
Tianjin 12
Falls Church 11
San Francisco 10
Seattle 9
Shenyang 9
Cassino 8
Los Angeles 8
Verona 8
Lanzhou 7
Salerno 7
Fairfield 6
Hangzhou 6
Hong Kong 6
Pune 6
Haikou 5
Ningbo 4
Singapore 4
Changchun 3
Hanover 3
Norwalk 3
Tappahannock 3
Tokyo 3
Toronto 3
Zhengzhou 3
Auburn Hills 2
Cambridge 2
Canberra 2
Frankfurt am Main 2
Houston 2
Jinan 2
Katowice 2
Kocaeli 2
Luxembourg 2
Melbourne 2
Olomouc 2
Redwood City 2
Saint Petersburg 2
Walnut 2
Washington 2
Almaty 1
Amsterdam 1
Athens 1
Auckland 1
Bengaluru 1
Berlin 1
Bonndorf 1
Centurion 1
Clearwater 1
Copenhagen 1
Fuzhou 1
Groningen 1
Guangzhou 1
Hefei 1
Langfang 1
Las Vegas 1
London 1
Philadelphia 1
Phoenix 1
Redmond 1
Riyadh 1
Rotherham 1
San Diego 1
San Jose 1
Shaoxing 1
Taizhou 1
Trieste 1
Vienna 1
Vientiane 1
Totale 2.347
Nome #
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling 148
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. 122
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation. 118
Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cells. 103
The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage: implications for therapy of drug resistant breast cancers. 98
Caspase-9 is the upstream caspase activated by 8-methoxypsoralen and ultraviolet-A radiation treatment of Jurkat T leukemia cells and normal T lymphocytes 96
Two hits are better than one: targeting both phosphatidylinositol3-kinase and mammalian target of rapamycin as a therapeuticstrategy for acute leukemia treatment 88
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells 85
Supravital exposure to propidium iodide identifies apoptosis on adherent cells. 85
The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism. 85
Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway 85
Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways. 83
Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome. 83
A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia. 82
Diacylglycerol kinase-theta is localized in the speckle domains of the nucleus. 81
Metabolism and signaling activities of nuclear lipids. 81
HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand 81
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the proapoptotic NF-κB 81
Radiobiologic response of medulloblastoma cell lines: involvement of beta-catenin? 80
Detection of serine 473 phosphorylated Akt in acute myeloid leukaemia blasts by flow cytometry 80
PI3K paninhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors 79
Intranucleolar localization of DNA topoisomerase IIalpha is a distinctive feature of necrotic, but not of apoptotic, Jurkat T-cells. 77
Targeting Signaling Pathways in T-cell acute lymphoblastic leukemia initiating cells 77
Flow cytometric detection of total and serine 473 phosphorylated Akt. 77
Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. 77
Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulation of PC12 cells. 76
The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression. 76
The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis. 76
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells. 75
Antiapoptotic role of p38 mitogen activated protein kinase in Jurkat T cells and normal human T lymphocytes treated with 8-methoxypsoralen and ultraviolet-A radiation. 75
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation. 75
Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia 75
Molecular characterization of protein kinase C-alpha binding to lamin A. 75
The controversial nuclear matrix: a balanced point of view. 75
The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. 74
Application of flow cytometry to molecular medicine: detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts. 71
Targeting the liver kinaseB1/AMP-activated protein kinasepathway as a therapeutic strategyfor hematological malignancies 70
Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway 70
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting 69
Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device. 67
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-amine (A443654) in T-cell acute lymphoblastic leukemia. 66
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia. 65
Involvement of the phosphoinositide 3-kinase/Akt signaling pathway in the resistance to therapeutic treatments of human leukemias. 59
Nuclear translocation of PKC-α is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs) 56
Therapeutic targeting of CK2 in acute and chronic leukemias 56
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (Review) 51
Totale 3.684
Categoria #
all - tutte 14.139
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.139


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019159 0 0 0 0 0 0 0 0 0 0 0 159
2019/2020376 95 4 4 35 5 63 22 57 6 12 69 4
2020/2021408 55 4 62 49 1 54 5 47 1 53 9 68
2021/2022345 7 4 1 26 35 9 7 34 10 17 69 126
2022/20231.568 103 145 57 154 87 261 0 93 622 5 17 24
2023/2024194 24 16 19 3 6 13 26 16 58 4 2 7
Totale 3.684